Logo

Ben Ho Park

Jun 01, 2018

Vanderbilt has announced that Ben Ho Park has been named co-leader of the breast cancer research program, director of the precision oncology, and associate director for translational research at the Vanderbilt-Ingram Cancer Center. Park, who will assume the post Sept. 1, succeeds Carlos Arteaga. Park currently serves as professor of oncology in the bresat and ovarian cancer program, associate director for research training and education, and member of the executive oversight committee at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University. Park received his undergraduate degree from the University of Chicago, followed by dual training at the University of Pennsylvania School of Medicine. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.